4//SEC Filing
Galletta Christopher 4
Accession 0000950170-24-137255
CIK 0001563880other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:30 PM ET
Size
7.0 KB
Accession
0000950170-24-137255
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-12-13$0.51/sh+15,000$7,665→ 19,935 total - Exercise/Conversion
Stock Option (right to buy)
2024-12-13−15,000→ 20,000 totalExercise: $0.51Exp: 2032-02-10→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Includes 4,935 shares purchased through the Issuer's employee stock purchase plan.
- [F2]This option was granted on February 11, 2022. The 35,000 shares of common stock underlying the option vested as to 25% of the shares on February 11, 2023 and vest as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001486099
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:30 PM ET
- Size
- 7.0 KB